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Recent ﬁndings showed the presence of a reciprocal relationship between thyroid hor-
mones and ghrelin, although the exact mechanism is not known. Design: Our study is
addressedtoevaluatetheeffectofacuteexogenousrhTSHadministrationonserumghrelin
levels in athyreotic patients on replacement l-thyroxine therapy.The study group included
50 patients (16 males and 34 females) submitted to total thyroidectomy and 131-iodine
remnant ablation for differentiated thyroid cancer on l-thyroxine therapy. Mean age was
47 .5±16.5years and mean BMI was 25.6±5.01kg/m2. rhTSH was administrated at the
dosage of 0.9mg i.m. once daily for two consecutive days. Blood samples were taken
between 08.00 and 09.00 after a overnight fasting for measurement ofTSH, FT3, FT4, and
ghrelin before the ﬁrst administration of rhTSH and for measurement of TSH and ghrelin
24, 48, 72, and 96h after the ﬁrst administration of rhTSH. Results: Mean±SD values
of basalTSH were 0.54±0.77μU/ml without signiﬁcant difference between females and
males. As expected, after rhTSH administration TSH concentrations increased at 24 and
48hwithpeakTSHvaluesrangingfrom20.20to313μU/ml(mean±SD98.4±66.7μU/ml).
Mean±SD values of basal ghrelin were 1085±373pg/ml without signiﬁcant difference
between males and females. After rhTSH administration ghrelin concentrations decreased
signiﬁcantly (p <0.01) at 24h (mean±SD 934±314pg/ml p <0.01) and returned to pre-
treatment levels at 96h. Conclusion: Our study demonstrates that acute exogenousTSH
administration has a suppressive effect on ghrelin secretion independent from changes in
thyroid status.
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INTRODUCTION
Ghrelin, an acylated 28-amino acid ligand for the growth hor-
mone secretagogue receptor (GHS-R), is produced principally
by the neuroendocrine X/A cells of the gastric mucosa (Kojima
and Kangawa, 2005). It was also identiﬁed in the pituitary gland,
hypothalamus, pancreas, and others tissues (Date and Kojima,
2000). At the hypothalamic level, ghrelin stimulates GH release
and regulates appetite and energy balance (Waren and Small,
2000; Ghigo and Arvat, 2001). Increased levels are seen in cata-
bolicconditions(MisraandMiller,2005),anddecreasedlevelsare
foundinobesepatients(MarchesiniandBianchi,2004).Moreover,
an inverse correlation between serum ghrelin levels and resting
energy expenditure (REE) has been recorded in healthy women
(Kamiji and Troncon, 2010). Thyroid disease is associated with
changes in appetite, food intake, and REE. Previous studies have
reported decreased levels of ghrelin in hyperthyroidism (Altinova
and Toruner, 2006a) and increased levels in hypothyroid patients
(Gjedde andVestergaard,2008; Kosowicz and Baumann-Antczak,
2011). On the other hand it has been recently demonstrated the
presence of mRNA of GHS-R in thyroid tissues (Ueberberg and
Abbreviations: BMI, body mass index; GHS-R, growth hormone secretagogue
receptor; TSH, thyroid stimulating hormone.
Unger, 2009) and a stimulating effect of ghrelin on FT4 secre-
tion in vivo (Kluge and Riedl,2010),suggesting a reciprocal effect
between ghrelin and thyroid hormones. Since previous studies
were conducted in patients with abnormal thyroid hormone lev-
els (hyperthyroidism and hypothyroidism) they could not assess
the direct role of TSH on ghrelin secretion. The present study was
designed in athyreotic patients in stable replacement l-thyroxine
therapy and normal TSH to study the effect of exogenous TSH
administration independent of thyroid status.
PATIENTS AND METHODS
The study group included 50 patients (16 males and 34
females) submitted to total thyroidectomy and 131-iodine rem-
nant ablation for differentiated thyroid cancer. Mean age was
47.5±16.5years and mean BMI was 25.6±5.01kg/m2. Twenty-
eight patients with persistent disease or at high risk, received
l-thyroxine in suppressive or semisuppressive doses (target TSH
<0.5μIU/mL), 22 patients, who had previous evidence of com-
pleteremission,weretreatedwithreplacementdosesofl-thyroxine
aimed to maintain normal TSH concentration.
PatientswerescheduledtoreceiverhTSH(Thyrogen;Genzyme
Therapeutics, Cambridge, MA, USA) for periodic staging of their
disease.rhTSHwasadministratedatthedosageof0.9mgi.m.once
daily for two consecutive days according to conventional protocol
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(Pacini and Ladenson, 2006). Blood samples were taken between
08.00and09.00afteraovernightfastingformeasurementof TSH,
FT3, FT4, and ghrelin before the ﬁrst administration of rhTSH
and for measurement of only TSH and ghrelin 24,48,72,and 96h
after the ﬁrst administration of rhTSH.
Serum total ghrelin was determined by a validated radioim-
munoassay (RIA;Mediagnost,Reutlingen,Germany) with a func-
tional sensitivity described by the manufacturer of 0.04ng/ml;
the normal range is 600–1400pg/ml. Serum TSH was deter-
minedbyacommerciallychemiluminescentassay(Immulite2000,
third generation TSH,LosAngeles,CA,USA; EURO/DPC limited
Lamberies, Gwynedd, UK).
STATISTICAL ANALYSIS
Data are presented as mean±SD. Statistical analysis was per-
formed using the Mann–Whitney test when comparing non-
parametric data. Areas under the serum concentration curves
(AUC) of ghrelin and TSH were calculated for the intervals 0–
96h by applying the trapezoid rule. One-way ANOVA was con-
ducted to compare serum ghrelin concentration at various time
points. Post hoc comparisons were conducted using Bonferroni’s
correction. Correlations between the variables were analyzed by
PearsonanalysisusingtheGraphPadPrismversion3.0.Statistical
signiﬁcance was deﬁned as p value<0.05.
RESULTS
Mean±SD values of basal TSH were 0.54±0.77μU/ml with-
outsigniﬁcantdifferencebetweenfemalesandmales.Asexpected,
after rhTSH administration TSH concentrations increased at
24 and 48h with peak TSH values ranging 20.2–313μU/ml
(mean±SD 98.4±66.7μU/ml). In most patients (42 patients)
the peak serum TSH was observed 48h after the second rhTSH
injection. The TSH–AUC was positively associated with age
(r =0.55, p <0.0001), but not with BMI. Mean±SD values
of basal ghrelin were 1085±373pg/ml without signiﬁcant dif-
ference between males and females. After rhTSH administra-
tion ghrelin concentrations decreased signiﬁcantly (p <0.01) at
24h (mean±SD 934±314pg/ml p <0.01) and returned to pre-
treatment levels at 96h (Figure 1). As shown in Figure 2 a
negative correlation between ghrelin AUC and BMI was observed
(r =−0.37,p =0.008).
DISCUSSION
In vitro studies demonstrated that both ghrelin and GHR-S are
expressed in normal and neoplastic thyroid glands (Gnanapa-
van and Kola, 2002; Zhang and Wang, 2006; Karaoglu and Aydin,
2009; Ueberberg and Unger, 2009) and a reciprocal relationship
between thyroid hormones and ghrelin levels has been demon-
strated (Chrysanthia and Franchi, 2007). In vivo some stud-
ies have shown that ghrelin levels are reduced in overt hyper-
thyroidism, but not in subclinical hyperthyroidism (Tanda and
Lombardi, 2009), and are normalized after correction of hyper-
thyroidism (Riis and Hansen, 2003). However it is not clear
whether ghrelin reduction is a consequence of excess thyroid
hormones or secondary to the hyperinsulinemic status associ-
ated with hyperthyroidism (Gimenez-Palop and Gimenez-Perez,
FIGURE 1 | Changes of serum ghrelin concentrations after rhTSH
stimulation.
FIGURE 2 | Correlation between ghrelinAUC after rhTSH
administration and BMI.
2005). More conﬂicting data are reported in hypothyroid patients
with studies showing higher,normal,and even lower serum ghre-
lin levels (Gimenez-Palop and Gimenez-Perez, 2005; Altinova
and Toruner, 2006b; Gjedde and Vestergaard, 2008; Tanda and
Lombardi, 2009).
Our model of athyreotic patients replaced with l-thyroxine
consented to study the effect of TSH on ghrelin concentrations
independently of thyroid status. We observed a decrease of ghre-
lin levels in the ﬁrst 24h from rhTSH administration return-
ing to baseline thereafter. We did not observe gender difference
in TSH-stimulated ghrelin concentrations, but, as expected, we
found a negative correlation between basal and TSH-stimulated
ghrelin levels and BMI. The observation that the correlation per-
sists also after TSH stimulation is an indication that the effect
of TSH is a true biological phenomenon rather than a fortu-
itous ﬁnding. Although we injected pharmacological doses of
rhTSH, we want to notice that the TSH levels achieved in the
blood are similar to those obtained after thyroid hormone with-
drawal in thyroid cancer patients undergoing routine follow-up
examination.
Inconclusion,ourstudyshowsthatamodulatoractionof TSH
isoperatingatgastricmucosaonghrelinsecretion,atleastatacute
pharmacological doses.
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